{"title":"Cationic polypeptide design for polyion complex-mediated mRNA delivery","authors":"Mitsuru Naito, K. Miyata","doi":"10.2745/dds.37.221","DOIUrl":null,"url":null,"abstract":"Recently, with the success of the COVID-19 vaccine, mRNA therapeutics have received a great deal of attention as a next-generation biopharmaceutical. One of the current key issues in mRNA therapeutics is the development of delivery vehicles with higher safety and targetability, excepting the liver. Herein, we introduce a systematic design strategy of cationic polypeptides and their polyplexes for enhanced mRNA delivery. Indeed, a series of cationic polypeptides were synthesized by the aminolysis reaction of poly(β-benzyl-L-aspartate)with varying amine compounds. First, cationic polyaspartamide derivatives were developed for efficient endosomal escape(or endosomal membrane destabilization)by highlighting the acidic pH-sensitivity of aminoethylene(-NHCH2 CH2-)units. Notably, a polyaspartamide derivative(PAsp(DET)) bearing diethylenetriamine(DET)moieties allowed efficient endosomal escape of polyplexes with lowered cytotoxicity. Second, varying hydrophobic moieties were introduced into the side chains of polyaspartamide derivative with the DET moieties to enhance the stability of mRNA-loaded polyplexes. The results indicated that the derivatives with a hydrophobicity index(or logD) > –2.4 elicited efficient mRNA transfection in cultured cells. As a result, a polyaspartamide derivative(PAsp(DET/CHE))with DET and cyclohexylethyl(CHE)moieties achieved the most efficient mRNA transfection without marked cytotoxicity, allowing the topical mRNA delivery in the ventricle via intracranial/intrathecal administration and the systemic mRNA delivery into the lung via intravenous administration. Third, self-catalytic degradation of cationic polyaspartamide derivatives was investigated by slightly changing the spacer length in the side chains. The main-chain degradation was substantially affected by the spacer length;the loss of one methylene spacer resulted in the 5-fold higher degradation rate. A polyaspartamide derivative(PAsp(EDA)) bearing the shorter spacer showed higher mRNA transfection efficiency in cultured cells with reduced cytotoxicity with an increase in pre-incubation time, compared with those bearing the longer spacers. Altogether, it is demonstrated that the polyplex-mediated mRNA delivery can be dramatically improved by fine-tuning the chemical structure of cationic polypeptides. © 2022, Japan Society of Drug Delivery System. All rights reserved.","PeriodicalId":11331,"journal":{"name":"Drug Delivery System","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Delivery System","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2745/dds.37.221","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
阳离子多肽设计用于聚离子复合物介导的信使核糖核酸递送
最近,随着新冠病毒疫苗的成功,mRNA治疗剂作为新一代生物制药备受关注。目前mRNA治疗的关键问题之一是开发具有更高安全性和靶向性的递送载体,肝脏除外。在此,我们介绍了一种系统的设计策略,阳离子多肽及其多聚体,以增强mRNA的传递。通过不同胺类化合物对聚β-苄- l-天冬氨酸的氨解反应,合成了一系列阳离子多肽。首先,通过强调氨基(- nhch2 - CH2-)单元的酸性ph敏感性,开发了阳离子聚天冬酰胺衍生物,用于有效的内体逃逸(或内体膜不稳定)。值得注意的是,含有二乙烯三胺(DET)部分的聚天冬酰胺衍生物(PAsp(DET))可以有效地使多聚体内体逃逸,降低细胞毒性。其次,在聚天冬酰胺衍生物的侧链中引入不同的疏水基团与DET基团,以提高mrna负载复合物的稳定性。结果表明,疏水指数(或logD)为> -2.4的衍生物可在培养细胞中高效转染mRNA。结果,聚天冬酰胺衍生物(PAsp(DET/CHE))具有DET和环己基乙基(CHE)部分,实现了最有效的mRNA转染,没有明显的细胞毒性,允许通过颅内/鞘内给药在脑室局部传递mRNA,并通过静脉给药在肺部全身传递mRNA。第三,通过改变侧链上的间隔长度,研究了阳离子聚阿斯巴胺衍生物的自催化降解。主链的降解主要受间隔段长度的影响,每减少一个亚甲基间隔段,降解率提高5倍。与具有较长间隔的细胞相比,具有较短间隔的聚阿斯巴胺衍生物(PAsp(EDA))在培养细胞中表现出更高的mRNA转染效率,并且随着预孵育时间的增加,细胞毒性降低。总之,研究表明,通过微调阳离子多肽的化学结构,可以显著改善多聚体介导的mRNA传递。©2022,日本药物输送系统协会。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。